SCHEMBL12438701

SCHEMBL12438701

COCCn1[nH]c2cc(=O)n(Cc3cccc(OC)c3)c(OCc3ccc(F)cc3)c2c1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOX4 Q9NPH5 5/20 0.48
CYP1A2 P05177 7/20 0.44
CYP3A4 P08684 7/20 0.44
CYP2C19 P33261 5/20 0.44
CYP2C9 P11712 5/20 0.44
ALDH1A1 P00352 5/20 0.44
LMNA P02545 4/20 0.44
USP2 O75604 3/20 0.44
PKM P14618 1/20 0.42
MAOB P27338 1/20 0.42
CYP2D6 P10635 4/20 0.42
MAPK1 P28482 2/20 0.42
ALOX15 P16050 1/20 0.42
TSHR P16473 2/20 0.41
CASP1 P29466 3/20 0.40
HSD17B10 Q99714 2/20 0.40
CASP7 P55210 2/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CYBB P04839 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2211894 0.86 NOX4 (0.62) NOX4CYP1A2CYP3A4CYP2C19CYP2C9
SCHEMBL12438694 0.83 NOX4 (0.69) NOX4CYP1A2CYP3A4CYP2C19CYP2C9
SCHEMBL2211989 0.77 NOX4 (0.47) NOX4CYP1A2CYP3A4CYP2C19CYP2C9
SCHEMBL2214709 0.72 NOX4 (0.62) NOX4USP2CYBBMAPT
SCHEMBL2220132 0.71 NOX4 (0.46) NOX4CYP2C19CYP2C9CYBBNOX5
SCHEMBL2211949 0.69 NOX4 (0.69) NOX4CYP3A4CYBBNOX5NOX1
SCHEMBL2219146 0.69 NOX4 (0.46) NOX4CYP1A2CYP3A4CYP2C19CYP2C9
SCHEMBL2210559 0.69 NOX4 (0.64) NOX4CYP1A2CYP3A4CYP2C19CYP2C9
SCHEMBL12438698 0.68 NOX4 (0.61) NOX4CYP1A2CYP3A4ALDH1A1LMNA
SCHEMBL2216533 0.68 KMT2A (0.43) NOX4CYP1A2CYP3A4CYP2C19CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8455486-B2 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors GENKYOTEX SA (CH) 2013-06-04 US disclosed
US-8455486-B2 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors GENKYOTEX SA (CH) 2013-06-04 US disclosed
US-20110178082-A1 PYRAZOLO PYRIDINE DERIVATIVES AS NADPH OXIDASE INHIBITORS GENKYOTEX SA (CH) 2011-07-21 US disclosed
US-20110178082-A1 PYRAZOLO PYRIDINE DERIVATIVES AS NADPH OXIDASE INHIBITORS GENKYOTEX SA (CH) 2011-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110178082-A1 PYRAZOLO PYRIDINE DERIVATIVES AS NADPH OXIDASE INHIBITORS NOX1, NOX4, CYBB NOX4 2/4885CYP1A2 63/4885CYP3A4 157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.